Skip to content

Reversal of muscle relaxation used in anesthesia: comparison of different doses of the reverser in children

Comparison of the Effect of Different Doses of Neostigmine on Reversal of Rocuronium-Induced Neuromuscular Blockade in Children Undergoing General Anesthesia: Prospective Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-4xrx2g3
Enrollment
Unknown
Registered
2024-04-25
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child

Interventions

This is a randomized controlled trial with four arms, double-blind. A total of 120 eligible individuals will be randomly allocated to one of the intervention groups using a randomization program from

Sponsors

Faculdade de Ciências Médicas e da Saúde da Pontifícia Universidade Católica de São Paulo
Lead Sponsor
Faculdade de Ciências Médicas e da Saúde da Pontifícia Universidade Católica de São Paulo
Collaborator

Eligibility

Age
2 Years to 10 Years

Inclusion criteria

Inclusion criteria: children aged 2 to 10; classified as American Society of Anesthesiologists (ASA) physical status I and II; undergoing general anesthesia for tonsillectomy with or without adenoidectomy

Exclusion criteria

Exclusion criteria: refusal to participate in the study; presence of renal disease; presence of hepatic disease; presence of neuromuscular disease; contraindication to the use of any of the drugs used in the study; body mass index equal to or greater than 30; acute clinical illnesses

Design outcomes

Primary

MeasureTime frame
Determine if there is a significant difference in the time elapsed between Train of Four (TOF) 3 and 100% between the groups

Secondary

MeasureTime frame
To analyze whether the incidence of bradycardia, respiratory complications and postoperative nausea and vomiting has a significant difference between the groups

Countries

Brazil

Contacts

Public ContactAntonio Moron Morad Neto

Faculdade de Ciências Médicas e da Saúde da Pontifícia Universidade Católica de São Paulo

juarezmoron@gmail.com+55(15)3212-9900

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: May 10, 2026